Blocking telomere damage signals restores blood cell production in aged mice
Two studies in Nature Aging found that therapeutic inhibition of the DNA damage response at telomeres reversed hematopoietic dysfunction in telomerase-deficient and physiologically aged mice, reducing senescence burden and inflammation while restoring stem cell function. In vitro experiments suggested the approach also improved human blood stem cell performance.